Market revenue in 2023 | USD 583.0 million |
Market revenue in 2030 | USD 944.7 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Peripheral stents |
Fastest growing segment | PTA Balloons |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Peripheral stents was the largest segment with a revenue share of 17.58% in 2023. Horizon Databook has segmented the China peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
The China peripheral vascular devices market growth can be attributed to the active participation of major international medical device corporations and local entities. Prominent global players, including Medtronic, Boston Scientific, Abbott Laboratories, Cook Medical, and Terumo Corporation, are pivotal contributors to the market landscape. Simultaneously, noteworthy local players like MicroPort and Lepu Medical play significant roles.
The market is expected to witness intense competition, with several major players vying for a larger revenue share. The market is expected to continue its growth trend due to the increasing prevalence of peripheral vascular diseases and technological advancements in the medical industry. Moreover, industry key players are also involved in strategic partnerships for product portfolio expansion, which is expected to contribute to market growth.
For instance, in March 2024, Zylox-Tonbridge recently unveiled a strategic alliance with Avinger, encompassing an exclusive entitlement for Zylox-Tonbridge to localize, produce, and market Avinger’s entire product portfolio across Greater China, spanning Mainland China, Hong Kong, Taiwan, and Macau. In addition, a technology transfer agreement was established, enabling Zylox-Tonbridge to utilize its cost-efficient manufacturing capabilities to support Avinger’s global sales beyond the Greater China region.
Horizon Databook provides a detailed overview of country-level data and insights on the China peripheral vascular devices market, including forecasts for subscribers. This country databook contains high-level insights into China peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account